SHALLAK, MARIAM
 Distribuzione geografica
Continente #
EU - Europa 317
NA - Nord America 283
AS - Asia 47
Totale 647
Nazione #
US - Stati Uniti d'America 279
IT - Italia 191
DE - Germania 36
SE - Svezia 25
SG - Singapore 23
IE - Irlanda 19
FI - Finlandia 13
CN - Cina 10
RU - Federazione Russa 10
UA - Ucraina 8
GB - Regno Unito 7
VN - Vietnam 6
CA - Canada 4
IN - India 3
JP - Giappone 3
FR - Francia 2
AT - Austria 1
CZ - Repubblica Ceca 1
ES - Italia 1
HK - Hong Kong 1
MD - Moldavia 1
NL - Olanda 1
PL - Polonia 1
UZ - Uzbekistan 1
Totale 647
Città #
Milan 54
Como 41
Ashburn 29
Chandler 26
Singapore 23
Fairfield 20
Nyköping 20
Dublin 19
Munich 19
Boardman 18
New York 18
Gallarate 17
Helsinki 13
Seattle 11
Woodbridge 11
Princeton 10
Chicago 9
Wilmington 9
Ann Arbor 8
Jacksonville 7
Magnago 7
Houston 6
Berlin 5
Dong Ket 5
Giussano 5
Ogden 5
Cambridge 4
Los Angeles 4
Naples 4
Rome 4
Santa Clara 4
Washington 4
West Jordan 4
London 3
Vanzago 3
Varese 3
Aprilia 2
Bergamo 2
Busto Arsizio 2
Norwalk 2
Ottawa 2
Pune 2
San Diego 2
Tokyo 2
Toronto 2
Verona 2
Wilnsdorf 2
Alzate Brianza 1
Beijing 1
Brno 1
Changsha 1
Dallas 1
Edinburgh 1
Frankfurt am Main 1
Guwahati 1
High Point 1
Hounslow 1
Jinan 1
Kilburn 1
Legnano 1
Madrid 1
Messina 1
Newark 1
Parrano 1
Prescot 1
Redmond 1
Redwood City 1
Shanghai 1
Shenyang 1
Siena 1
Springfield 1
Tashkent 1
Turin 1
Vicenza 1
Vienna 1
Wuhan 1
Totale 503
Nome #
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1 105
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients 90
Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T cell leukemia 76
Unveiling the hidden treasury: Ciita-driven mhc class ii expression in tumor cells to dig up the relevant repertoire of tumor antigens for optimal stimulation of tumor specific cd4+ t helper cells 64
Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells 61
Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma 52
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine 47
Htlv-1 infection and pathogenesis: New insights from cellular and animal models 36
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA 34
A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line 27
The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing 27
The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy 19
HTLV-1 Infection and Adult T Cell Leukemia Mechanisms of Oncogenesis and Alteration of Immunity 14
Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma 14
An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma 12
A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells 11
Totale 689
Categoria #
all - tutte 4.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.478


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 4 6 10 5 3 1 2
2020/202160 1 2 3 2 1 3 4 4 19 8 5 8
2021/202270 5 1 2 6 1 5 1 10 9 9 15 6
2022/2023140 9 3 10 5 18 21 1 19 21 10 19 4
2023/2024211 21 11 21 48 38 37 1 6 6 6 0 16
2024/2025177 5 1 61 52 40 18 0 0 0 0 0 0
Totale 689